Assessment of co-resistance to antibiotics recommended for acute pyelonephritis among Escherichia coli clinical strains from community- and nursing home–acquired urinary tract infections
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkae431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Anne-Gaëlle Leroy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre d'Appui à la Prévention des Infections Associées aux Soins des Pays de la Loire, Centre Hospitalier Universitaire (CHU)-Le Tourville, Nantes, …. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Escherichia coli, Urinary Tract Infections, Escherichia coli Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, France 2030.
Themen: Langzeitpflege
Abstract (Originalsprache)
Objectives
This study aimed to assess the frequency of co-resistance to antibiotics recommended in acute pyelonephritis among Escherichia coli clinical strains isolated from urinary tract infections (UTIs) acquired in community or nursing homes (NHs), and to identify situations without alternatives to fluoroquinolones (FQs).
Methods
All antimicrobial susceptibility test (AST) results of E. coli culture-positive urine samples from females living in the community or in NHs, collected through a large network of clinical laboratories in 2020 in France, were included. The percentages of strains resistant to amoxicillin alone or combined with a resistance to one to four alternatives among amoxicillin/clavulanic acid, trimethoprim/sulfamethoxazole, cefixime and FQs were calculated and compared between age categories and settings.
Results
Among 291 367 E. coli strains from community-acquired UTIs, 60.3% were susceptible to amoxicillin (<65-year-olds: 61.8% versus ≥65-year-olds: 58.8%; P < 0.001), and 99.1% to oral alternatives to FQs. Co-resistance to amoxicillin and trimethoprim/sulfamethoxazole was higher among females ≥65 years old versus <65 years old (7.1% versus 6.1%; P < 0.01), as well as co-resistance to amoxicillin, amoxicillin/clavulanic acid and trimethoprim/sulfamethoxazole (8.6% versus 10%; P < 0.001). Among 11 340 strains from NH UTIs, 51.2% were susceptible to amoxicillin, and 98% to oral alternatives to FQs. Co-resistance to amoxicillin, amoxicillin/clavulanic acid and/or cefixime was higher in isolates from females ≥65 years old living in NHs versus in the community (respectively 11.9% versus 15.3%, P < 0.001; 0.8% versus 2.8%, P < 0.01; 1.7% versus 4.4%, P < 0.01).
Conclusions
Based on AST results, prescribing oral alternatives to FQs for females may be possible in ≥99% of E. coli acute pyelonephritis cases in the community, and ≥98% in NHs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre d'Appui à la Prévention des Infections Associées aux Soins des Pays de la Loire, Centre Hospitalier Universitaire (CHU)-Le Tourville, Nantes, France.
- French National Surveillance System of Antimicrobial Resistance in Primary Care and Nursing Homes, PRIMO, CHU-Le Tourville, Nantes, France.
- Department of Infectious Diseases, University Hospital of Nantes and Centre d'Investigation Clinique 1413, Institut National de la Santé et de la Recherche Médicale, Nantes, CHU Nantes, Pays de la Loire, Nantes, France.
- Service des Maladies Infectieuses, CHU Grenoble-Alpes, Grenoble, France.
- Cibles et Médicaments des Infections et de l'Immunité, IICiMed, Nantes Université, Nantes, France.
ORCID-Profile: Anne-Gaëlle Leroy, David Boutoille, Gabriel Birgand
Förderung
- Agence Nationale de la Recherche
- France 2030
Zitieren
APA
Leroy, A. G., Lemenand, O., Thibaut, S., Coeffic, T., Chauveau, M., Lesprit, P., Caillon, J., Boutoille, D., Birgand, G., & French Clinical Laboratories Nationwide Network (2025). Assessment of co-resistance to antibiotics recommended for acute pyelonephritis among Escherichia coli clinical strains from community- and nursing home–acquired urinary tract infections. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae431
Vancouver
Leroy AG, Lemenand O, Thibaut S, Coeffic T, Chauveau M, Lesprit P, et al. Assessment of co-resistance to antibiotics recommended for acute pyelonephritis among Escherichia coli clinical strains from community- and nursing home–acquired urinary tract infections. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkae431
BibTeX
@article{Leroy2025,
author = {Leroy, Anne-Gaëlle and Lemenand, Olivier and Thibaut, Sonia and Coeffic, Thomas and Chauveau, Marie and Lesprit, Philippe and Caillon, Jocelyne and Boutoille, David and Birgand, Gabriel and French Clinical Laboratories Nationwide Network, French Clinical Laboratories Nationwide Network},
title = {Assessment of co-resistance to antibiotics recommended for acute pyelonephritis among Escherichia coli clinical strains from community- and nursing home–acquired urinary tract infections},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkae431}
}
EUVIMED